Chandelier
Senior Member (Voting Rights)
HSP60 and SARS-CoV-2: Les Liaisons Dangereuses
One of the key aspects discussed is the phenomenon of molecular mimicry, wherein Hsp60 exhibits epitope similarity with a number of SARS-CoV-2 proteins, a circumstance that may potentially culminate in the induction of autoimmune responses.
This mimicry has the potential to contribute to the development of autoimmune conditions, including Guillain–Barré syndrome and autoimmune thyroiditis, in patients infected with SARS-CoV-2.
The document discusses Hsp60’s role in endothelial damage and thromboembolic complications, suggesting it could serve as a biomarker for disease severity and a therapeutic target.
It raises concerns about vaccine safety due to Hsp60’s structural similarity to SARS-CoV-2 proteins, which may trigger autoimmune responses.
The potential for Hsp60 to generate anti-tumor immunity is explored, indicating that immune responses to SARS-CoV-2 might also target tumor cells with similar epitopes.
Further research is necessary to understand Hsp60’s role in disease fully and to develop effective therapeutic strategies.
Extracellular Hsp60 can interact with Toll-like receptors, amplifying inflammatory responses and contributing to cytokine storm and tissue damage.
Additionally, since the presence of several common epitopes with SARS-CoV-2 proteins, its role in molecular mimicry suggests a potential link also to post-infectious autoimmune disorders.
Hsp60 has also been implicated in endothelial damage and thromboembolic complications observed in severe COVID-19 cases.
Beyond its pathogenic roles, Hsp60 could emerge as a potential biomarker for disease severity as well as a target for therapeutic strategies aimed at modulating immune responses.
Finally, the structural similarity with SARS-CoV-2 proteins raises important considerations regarding both vaccine safety and the unexpected potential for anti-tumor immunity.
This review critically examines the multifaceted roles of Hsp60 in COVID-19, specifically from a morpho-functional point of view, highlighting its implications in disease progression, post-viral complications, and therapeutic opportunities.
Web | DOI | PMC | PDF | Biology | Open Access
Carista, Adelaide; Gratie, Melania Ionelia; Cappello, Francesco; Burgio, Stefano
Simple Summary
This review examines the role of heat shock protein 60 (Hsp60) in COVID-19, highlighting its impact on immune modulation, inflammation, and endothelial dysfunction. Hsp60, a chaperone protein essential for protein folding and protection against cell stress, has been linked to COVID-19 pathogenesis through its interactions with the immune system and potential involvement in post-infectious autoimmune processes.One of the key aspects discussed is the phenomenon of molecular mimicry, wherein Hsp60 exhibits epitope similarity with a number of SARS-CoV-2 proteins, a circumstance that may potentially culminate in the induction of autoimmune responses.
This mimicry has the potential to contribute to the development of autoimmune conditions, including Guillain–Barré syndrome and autoimmune thyroiditis, in patients infected with SARS-CoV-2.
The document discusses Hsp60’s role in endothelial damage and thromboembolic complications, suggesting it could serve as a biomarker for disease severity and a therapeutic target.
It raises concerns about vaccine safety due to Hsp60’s structural similarity to SARS-CoV-2 proteins, which may trigger autoimmune responses.
The potential for Hsp60 to generate anti-tumor immunity is explored, indicating that immune responses to SARS-CoV-2 might also target tumor cells with similar epitopes.
Further research is necessary to understand Hsp60’s role in disease fully and to develop effective therapeutic strategies.
Abstract
Heat shock protein 60 (Hsp60) plays a crucial role in cellular homeostasis and stress responses. Recent evidence highlights its involvement in COVID-19 pathophysiology, particularly in immune modulation, inflammation, and endothelial dysfunction.Extracellular Hsp60 can interact with Toll-like receptors, amplifying inflammatory responses and contributing to cytokine storm and tissue damage.
Additionally, since the presence of several common epitopes with SARS-CoV-2 proteins, its role in molecular mimicry suggests a potential link also to post-infectious autoimmune disorders.
Hsp60 has also been implicated in endothelial damage and thromboembolic complications observed in severe COVID-19 cases.
Beyond its pathogenic roles, Hsp60 could emerge as a potential biomarker for disease severity as well as a target for therapeutic strategies aimed at modulating immune responses.
Finally, the structural similarity with SARS-CoV-2 proteins raises important considerations regarding both vaccine safety and the unexpected potential for anti-tumor immunity.
This review critically examines the multifaceted roles of Hsp60 in COVID-19, specifically from a morpho-functional point of view, highlighting its implications in disease progression, post-viral complications, and therapeutic opportunities.
Web | DOI | PMC | PDF | Biology | Open Access